Literature DB >> 26092965

Development of a collaborative transitions-of-care program for heart failure patients.

Stephen Gunadi1, Suzanne Upfield2, Ngoc-Diep Pham2, Jenni Yea2, Maryliz Bayas Schmiedeberg2, Gift Deresoma Stahmer2.   

Abstract

PURPOSE: The development and implementation of a pharmacy-led transitions-of-care program to reduce the risk of readmission and increase satisfaction for heart failure (HF) patients are described.
SUMMARY: A transitions-of-care committee was established at Providence St. Peter Hospital, a 390-bed community teaching facility in Olympia, Washington, and focused on implementing standardized workflow processes for conducting admission medication review and discharge medication review and providing discharge counseling for patients with HF. All HF patients were to have admission medication reconciliation performed within 48 hours of admission. All HF patients were assigned a readmission risk complexity score after being admitted to the medical floor. The pharmacist, resident, and student performed daily patient medication profile reviews on all HF patients to ensure the use of optimal doses of appropriate HF medication regimens. The pharmacist proactively monitored for patient discharges using reports available in the electronic medical record. The pharmacist, resident, student, or HF nurse navigator counseled each patient on the discharge medications and answered any questions or addressed concerns regarding medications. Input from the quality-improvement specialist and data abstracter was used to ensure compliance with HF core measures. The program has resulted in an increase in core measure compliance and a reduction of HF, 30-day, and all-cause readmissions, and patient satisfaction scores have improved. For each avoided readmission, there was an associated decrease of $5652 in variable costs.
CONCLUSION: The implementation of a pharmacy-led transitions-of-care program improved patient care by prioritizing those who needed medication reconciliation and led to increases in HF core measure compliance and patient satisfaction scores.
Copyright © 2015 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26092965     DOI: 10.2146/ajhp140563

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Effect of health information technology (HIT)-based discharge transition interventions on patient readmissions and emergency room visits: a systematic review.

Authors:  Joanna Abraham; Alicia Meng; Sanjna Tripathy; Spyros Kitsiou; Thomas Kannampallil
Journal:  J Am Med Inform Assoc       Date:  2022-03-15       Impact factor: 4.497

Review 2.  The Role of the Nurse in the Management of Medicines During Transitional Care: A Systematic Review.

Authors:  Abbas Mardani; Pauline Griffiths; Mojtaba Vaismoradi
Journal:  J Multidiscip Healthc       Date:  2020-10-30

3.  Development and validation of a transitions-of-care pharmacist tool to predict potentially avoidable 30-day readmissions.

Authors:  Laura Hunt McAuliffe; Andrew R Zullo; Ruth Dapaah-Afriyie; Christine Berard-Collins
Journal:  Am J Health Syst Pharm       Date:  2018-02-01       Impact factor: 2.980

4.  Quantifying the relationship between patient characteristics and involvement in developing and implementing a treatment plan.

Authors:  Natalie T Roy; Erin E Ulrich
Journal:  Drug Healthc Patient Saf       Date:  2017-01-16

5.  Medication-related Problems in Intensive Care Unit Survivors: Learning from a Multicenter Program.

Authors:  Pamela MacTavish; Tara Quasim; Colin Purdie; Morna Ball; Lesley Barker; Sarah Connelly; Helen Devine; Philip Henderson; Lucy A Hogg; Rakesh Kishore; Phil Lucie; Jennifer Murphy; Peter O'Brien; Martin Shaw; Laura Strachan; Alan Timmins; Theodore J Iwashyna; Joanne McPeake
Journal:  Ann Am Thorac Soc       Date:  2020-10

Review 6.  A Review of the Role of the Pharmacist in Heart Failure Transition of Care.

Authors:  Sarah L Anderson; Joel C Marrs
Journal:  Adv Ther       Date:  2018-02-27       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.